Cx3cr1CreER knock-in/knock-out mice express tamoxifen-inducible Cre recombinase under the direction of the Cx3cr1 promoter in the mononuclear phagocyte system making them useful for fate-mapping studies of the monocyte and macrophage compartment, as well as microglia.
Steffen Jung, Weizmann Institute of Science
Genetic Background | Generation |
---|---|
N10+pN3
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Recombinase-expressing, Inducible) | Cx3cr1 | chemokine (C-X3-C motif) receptor 1 |
Cx3cr1CreER knock-in/knock-out mice express a Cre-ER fusion protein from endogenous Cx3cr1 promoter/enhancer elements. Insertion of the Cre-ER fusion protein knocks out endogenous CX3CR1 expression. CX3CR1 is a chemokine receptor expressed in the mononuclear phagocyte system, as well as microglia. Homozygous mice are viable and fertile. When Cx3cr1CreER mice are bred with mice containing loxP-flanked sequence, tamoxifen-inducible, Cre-mediated recombination will result in deletion of the floxed sequences.
For example, when bred to B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J mice (Stock No. 006148), cre-mediated recombination results in yellow fluorescent protein expression in microglia, and intestinal and kidney macrophages.
Additionally, very low levels of Cre activity may be present prior to introduction of tamoxifen - but the Cre activity after tamoxifen are significantly greater than those baseline levels. As such, it is recommended that researchers include tamoxifen-negative controls to establish any baseline levels of Cre activity in their experiments. For example, when Cx3cr1CreER are bred to the dual fluorescent reporter line mT/mG (Stock No. 007676), the resulting mice had some basal Cre activity (GFP expression) in a fraction of microglia prior to tamoxifen treatment, but the Cre activity upon tamoxifen treatment was significantly greater (almost completely restricted to microglia).
Of note, The Jackson Laboratory also has available Cx3cr1CreER mice with EYFP expression (Stock No. 021160).
A targeting vector was designed to replace exon 1 of the chemokine (C-X3-C) receptor 1 (Cx3cr1) gene with a CreER (Cre recombinase fused to an estrogen receptor ligand binding domain) coding sequence and a loxP-flanked neomycin (neo) resistance cassette. This construct was electroporated into 129P2/OlaHsd-derived E14 embryonic stem (ES) cells. Chimeras were made by ES cell aggregation with eight-cell stage embryos and chimeric mice were bred with Tg(Pgk1-cre)1Lni mice to delete the neo cassette. Resulting offspring were bred to remove the cre-expressing transgene, and progeny were bred with C57BL/6JOlaHsd inbred mice for at least 10 generations. Upon arrival at The Jackson Laboratory, mice were bred to C57BL/6J inbred mice (Stock No. 000664) for at least one generation to establish the colony.
Expressed Gene | cre/ERT2, Cre recombinase and estrogen receptor 1 (human) fusion gene, |
---|---|
Site of Expression | Mice express tamoxifen-inducible Cre recombinase in the mononuclear phagocyte system. |
Allele Name | targeted mutation 2.1, Steffen Jung |
---|---|
Allele Type | Targeted (Recombinase-expressing, Inducible) |
Allele Synonym(s) | Cx3cr1creER |
Gene Symbol and Name | Cx3cr1, chemokine (C-X3-C motif) receptor 1 |
Gene Synonym(s) | |
Promoter | Cx3cr1, chemokine (C-X3-C motif) receptor 1, mouse, laboratory |
Expressed Gene | cre/ERT2, Cre recombinase and estrogen receptor 1 (human) fusion gene, |
Site of Expression | Mice express tamoxifen-inducible Cre recombinase in the mononuclear phagocyte system. |
Strain of Origin | 129P2/OlaHsd |
Chromosome | 9 |
Molecular Note | A cre/ERT2 cassette with a floxed neo gene was inserted by RedE/T recombineering into a BAC containing the Cx3cr1 locus, replacing the coding exon of Cx3cr1. Properly targeted ES cells were aggregated with 8-cell embryos to generate chimeras. Chimeras were backcrossed to C57BL/6 mice. Tne neo was excised by crossing the animals to a cre deleter strain (Tg(Pgk1-cre)1Lni). |
When maintaining a live colony homozygous mice may be bred together.
When using the Cx3cr1CreER mouse strain in a publication, please cite the originating article(s) and include JAX stock #020940 in your Materials and Methods section.
Service/Product | Description | Price |
---|---|---|
Heterozygous for x3cr1<tm2.1(cre/ERT2)Jung> |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.